Insider Stock Trading History of Yancopoulos George


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Yancopoulos George since year 2005. The trader's CIK number is 1226690. At the time of this reporting, Yancopoulos George is the President Regeneron Laboratori of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Yancopoulos George since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-12-15 REGN Regeneron Pharmaceuticals Inc Option Ex 195,079 20.32 3,964,005
2015-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 1,921 52.03 99,949
2015-12-02 REGN Regeneron Pharmaceuticals Inc Sale 43,348 548.99 23,797,401
2015-10-30 REGN Regeneron Pharmaceuticals Inc Option Ex 182,818 11.64 2,128,001
2015-11-02 REGN Regeneron Pharmaceuticals Inc Sale 43,348 571.07 24,754,612
2014-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 3,264 30.63 99,976
2014-08-27 REGN Regeneron Pharmaceuticals Inc Option Ex 5,720 314.31 1,797,853
2014-02-11 REGN Regeneron Pharmaceuticals Inc Option Ex 189,463 9.49 1,798,003
2014-02-12 REGN Regeneron Pharmaceuticals Inc Sale 88,987 323.02 28,744,936
2013-12-19 REGN Regeneron Pharmaceuticals Inc Option Ex 4,705 21.25 99,981
2013-12-12 REGN Regeneron Pharmaceuticals Inc Option Ex 9,599 260.44 2,499,963
2013-05-06 REGN Regeneron Pharmaceuticals Inc Option Ex 192,308 13.00 2,500,004
2013-05-07 REGN Regeneron Pharmaceuticals Inc Sale 100,000 262.88 26,288,000
2012-12-19 REGN Regeneron Pharmaceuticals Inc Option Ex 50,846 15.53 789,536
2012-12-17 REGN Regeneron Pharmaceuticals Inc Option Ex 10,369 109.29 1,133,228
2012-05-01 REGN Regeneron Pharmaceuticals Inc Sale 33,165 134.59 4,463,776
2012-03-26 REGN Regeneron Pharmaceuticals Inc Sale 33,150 120.65 3,999,547
2012-02-15 REGN Regeneron Pharmaceuticals Inc Option Ex 133,332 8.50 1,133,322
2012-01-05 REGN Regeneron Pharmaceuticals Inc Sale 27,713 58.00 1,607,354
2011-11-30 REGN Regeneron Pharmaceuticals Inc Option Ex 200,000 28.01 5,602,000
2011-12-01 REGN Regeneron Pharmaceuticals Inc Sale 27,713 59.16 1,639,362
2009-12-03 REGN Regeneron Pharmaceuticals Inc Option Ex 100,000 8.77 877,000
2008-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 100,000 7.41 741,000
2008-12-16 REGN Regeneron Pharmaceuticals Inc Sale 26,991 16.40 442,652
2007-04-16 REGN Regeneron Pharmaceuticals Inc Sale 400 24.99 9,997
2007-04-13 REGN Regeneron Pharmaceuticals Inc Option Ex 90,444 10.56 955,359
2007-04-16 REGN Regeneron Pharmaceuticals Inc Sale 30,883 24.58 759,011
2007-04-09 REGN Regeneron Pharmaceuticals Inc Option Ex 9,556 10.56 100,940
2007-04-09 REGN Regeneron Pharmaceuticals Inc Sale 9,556 23.83 227,738
2006-01-09 REGN Regeneron Pharmaceuticals Inc Sale 900 17.24 15,512
2005-12-27 REGN Regeneron Pharmaceuticals Inc Option Ex 25,000 12.75 318,750
2005-12-27 REGN Regeneron Pharmaceuticals Inc Sale 5,500 14.87 81,801

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yancopoulos George (President Regeneron Laboratori of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.